Your Top 10 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6
Brett G.M. Hughes, Alexander David Guminski, Samantha Elizabeth Bowyer, Michael Robert Migden, Chrysalyne Delling Schmults, Nikhil I. Khushalani and 24 more
- Rank
- 9 of 2,395
- Percentile
- top 0.4%
- Where
- Journal of the American Academy of Dermatology, 2024
- Citations
- 72
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.